SETsquared-Bristol
Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at a glance: Market sector: Life Sciences Location: Bristol Number of employees: 25 Amount of funding raised: Over £16m Company growth status: Commercialisation Let’s start with GenomeKey’s…
Read MoreNeuroelectrics, a pioneer in high-definition brain stimulation and EEG technology, has partnered with Neuronostics, an innovator in advanced digital biomarkers and EEG analysis, to deliver an integrated EEG solution tailored for the pharmaceutical, contract research organizations (CROs) and academic partners. This collaboration combines Neuroelectrics’ cutting-edge EEG hardware with Neuronostics’ proprietary analytics to streamline clinical trials…
Read MoreWilder Sensing, a developer of software for biodiversity monitoring using audio and Artificial Intelligence (AI), has secured £700,000 in equity investment. The South West Investment Fund awarded £300,000 via appointed Fund Manager The FSE Group, and additional funding was provided by Oxford Innovation Finance and Cambridge Angels. The new capital will enable the company…
Read MoreIn a vibrant display of entrepreneurial spirit, the SETsquared Partnership highlighted the investment potential of university startups and spinouts at a high-profile event in London last month. Investment Futures attracted a dynamic crowd of over 300 attendees, bringing together university researchers, innovators, industry experts and investors interested in capitalising on groundbreaking tech innovation. Our companies…
Read MoreAnna-Lisa Wesley, Entrepreneur in Residence at SETsquared Bristol, reflects on the power of storytelling and needing new founder stories for our time. “Working in tech right now, we need some new heroes, heroines, new plots, new tools, new lessons. We desperately need new material.” Microsoft, Google, LinkedIn… these business stories, the founders that sit behind them and…
Read MoreLight Trace Photonics, a leading innovator in the integrated photonics industry, has announced the close of its first investment round of £600,000. The company was co-founded by University of Bristol PhD researcher Dr Jake Biele who joined our incubation programme in May 2024 to commercialise and grow the company. This capital injection, led by QantX…
Read MoreWe are delighted to announce that Rosie Bennett joins the Bristol Innovations team as Innovation Lead. Rosie Bennett’s brief is across Bristol Innovations’ portfolio of incubators, innovation hubs and networks; SETsquared Bristol, Engine Shed, the Quantum Technologies Innovation Centre, Quantum Frontier, and the University of Bristol’s joint venture with Science Creates. As Innovation Lead, Rosie…
Read MoreThe SETsquared Partnership universities and leading regional investment firm QantX have announced plans for a new £300m spin-out focused investment vehicle to catalyse the creation and growth of science and technology companies addressing global challenges. The initiative was announced by Sir Richard Olver, Chair of QantX, at Bristol City Hall on 11 October at the…
Read MoreAfter a wonderful few years working with SETsquared Bristol, my time at the tech incubator has come to an end as I move on to a new role as Head of Memberships for Capital Enterprise. I joined SETsquared Bristol in 2022 and became its Director in early 2023 with the aim to use my knowledge…
Read More